FDA Report “Coordinated Registry Networks to Bridge Clinical Care and Research”
This white paper “UDI: The Key to Unlock Personalized Medicine?” provides Life Sciences firms with the ability to see how the implementation of Unique Device Identification (UDI) is having a profound effect on Med-Tech manufacturers, healthcare providers, regulators and ultimately the patient.
President of Axendia Daniel R Matlis and Research Associate Ellyn McMullin explore how changes in regulations requiring a UDI on packaging of implantable, life-supporting and life-sustaining devices must bear a UDI and date.
In addition, FDA’s new report: “Coordinated Registry Networks to Bridge Clinical Care and Research” calls for the adoption of UDI in patient identification across the entire device life cycle.
Could UDI be a key that unlocks the potential of personalized medicine for the masses?
Complete the form to find out how.